FOXP3 and diabetes mellitus: Additionally, this work demonstrated that RAS inhibition improves Tregs’ immunosuppressive function in a FOXP3-dependent manner, which allowed RAS-deficient Tregs to prevent the development of diabetes in a mouse model of the disease by up to 70% [59].